186 related articles for article (PubMed ID: 28293713)
1. Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; De Michele T; Zuppi C; Bacigalupo AP; Sica S; Chiusolo P
Ann Hematol; 2017 Jun; 96(6):929-933. PubMed ID: 28293713
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin as a biomarker of intestinal graft versus host disease after allogeneic hematopoietic stem cell transplantation.
Lorenz F; Marklund S; Werner M; Palmqvist R; Wahlin BE; Wahlin A
Sci Rep; 2015 Jan; 5():7920. PubMed ID: 25605402
[TBL] [Abstract][Full Text] [Related]
3. Fecal calprotectin in allogeneic stem cell transplantation for the diagnosis of acute intestinal graft versus host disease.
Bastos Oreiro M; Castilla-Llorente C; de la Guía AL; de Paz R; Van Domselaar M; Nieto J; Rodriguez A; Gallardo D; Canales M;
Bone Marrow Transplant; 2012 Sep; 47(9):1241-2. PubMed ID: 22307017
[No Abstract] [Full Text] [Related]
4. Endoscopic and Histological Findings Are Predicted by Fecal Calprotectin in Acute Intestinal Graft-Versus-Host-Disease.
Adam B; Koldehoff M; Ditschkowski M; Gromke T; Hlinka M; Trenschel R; Kordeals L; Steckel NK; Beelen DW; Liebregts T
Dig Dis Sci; 2016 Jul; 61(7):2019-26. PubMed ID: 26995779
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin and serum albumin as markers of gastrointestinal graft versus host disease.
Broglie L; Rademaker A; Galvin J; Ray A; Tse WT; Duerst R; Schneiderman J; Kletzel M; Chaudhury S
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):169-174. PubMed ID: 29397331
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin and alpha-1 antitrypsin predict severity and response to corticosteroids in gastrointestinal graft-versus-host disease.
Rodriguez-Otero P; Porcher R; Peffault de Latour R; Contreras M; Bouhnik Y; Xhaard A; Andreoli A; Ribaud P; Kapel N; Janin A; Socié G; Robin M
Blood; 2012 Jun; 119(24):5909-17. PubMed ID: 22555971
[TBL] [Abstract][Full Text] [Related]
7. Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation.
Chiusolo P; Metafuni E; Giammarco S; Bellesi S; Piccirillo N; Fanali C; Castagnola M; Zuppi C; De Michele T; Leone G; Sica S
Blood; 2012 Nov; 120(22):4443-4. PubMed ID: 23175663
[No Abstract] [Full Text] [Related]
8. Fecal calprotectin and α1-antitrypsin dynamics in gastrointestinal GvHD.
O'Meara A; Kapel N; Xhaard A; Sicre de Fontbrune F; Manéné D; Dhedin N; de Latour RP; Socié G; Robin M
Bone Marrow Transplant; 2015 Aug; 50(8):1105-9. PubMed ID: 25961766
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
[TBL] [Abstract][Full Text] [Related]
10. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
11. The eukaryotic gut virome in hematopoietic stem cell transplantation: new clues in enteric graft-versus-host disease.
Legoff J; Resche-Rigon M; Bouquet J; Robin M; Naccache SN; Mercier-Delarue S; Federman S; Samayoa E; Rousseau C; Piron P; Kapel N; Simon F; Socié G; Chiu CY
Nat Med; 2017 Sep; 23(9):1080-1085. PubMed ID: 28759053
[TBL] [Abstract][Full Text] [Related]
12. Acute Steroid-Refractory Gastrointestinal Graft-Versus-Host Disease Is Not Associated With Significant Differences in Gut Taxonomic Composition Compared to Steroid-Sensitive Gastrointestinal Graft-Versus-Host Disease Immediately Before Onset of Disease.
Zeng K; Brewster R; Kang JB; Tkachenko E; Brooks E; Bhatt AS; Fodor AA; Andermann TM
Transplant Cell Ther; 2024 Feb; 30(2):237.e1-237.e9. PubMed ID: 37944820
[TBL] [Abstract][Full Text] [Related]
13. Predictive Value of Fecal Calprotectin in Pediatric Graft-Versus-Host Disease.
Wadhwani SI; Nakayuenyongsuk W; Shinn L; Chase P; Kharbanda S; Bass D; Park KT
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):e208-e209. PubMed ID: 27504814
[No Abstract] [Full Text] [Related]
14. Changes in protein serum levels during stem cell transplantation.
Metafuni E; Giammarco S; De Ritis DG; Rossi M; Corrente F; Piccirillo N; Bacigalupo AP; Sica S; Chiusolo P
Eur J Clin Invest; 2017 Oct; 47(10):711-718. PubMed ID: 28796281
[TBL] [Abstract][Full Text] [Related]
15. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease.
Eriguchi Y; Nakamura K; Hashimoto D; Shimoda S; Shimono N; Akashi K; Ayabe T; Teshima T
Transpl Infect Dis; 2015 Oct; 17(5):702-6. PubMed ID: 26198302
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
Chen CC; Huang JL; Chang CJ; Kong MS
J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin concentrations in adult dogs with chronic diarrhea.
Grellet A; Heilmann RM; Lecoindre P; Feugier A; Day MJ; Peeters D; Freiche V; Hernandez J; Grandjean D; Suchodolski JS; Steiner JM
Am J Vet Res; 2013 May; 74(5):706-11. PubMed ID: 23627383
[TBL] [Abstract][Full Text] [Related]
19. EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Faubion WA; Fletcher JG; O'Byrne S; Feagan BG; de Villiers WJ; Salzberg B; Plevy S; Proctor DD; Valentine JF; Higgins PD; Harris JM; Diehl L; Wright L; Tew GW; Luca D; Basu K; Keir ME
Am J Gastroenterol; 2013 Dec; 108(12):1891-900. PubMed ID: 24126633
[TBL] [Abstract][Full Text] [Related]
20. Relative defects in mucosal immunity predict acute graft-versus-host disease.
August KJ; Chiang KY; Qayed M; Dulson A; Worthington-White D; Cole CR; Horan JT
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1056-9. PubMed ID: 24641826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
